EQT AB

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP

W3R27C102
SEDOL

BJ7W9K4
CIK

0000033213

eqtgroup.com
LEI: 213800U7P9GOIRKCTB34
FIGI: BBG00Q57JLK2
EQT

EQT AB
GICS: 40203010 · Sektor: Financials · Sub-Sektor: Financial Services
AI
PROFILER
NAME
EQT AB
ISIN
SE0012853455
TICKER
EQT
MIC
XSTO
REUTERS
EQT.ST
BLOOMBERG
EQT SS
FÜR INVESTOREN
FÜR TRADER

Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von PR-Newswire bereitgestellt.

Di., 04.03.2025       EQT
SE0012853455

The sale resulted in aggregate gross proceeds of c. EUR 366 million, of which EQT received c. EUR 333 million

NEW YORK, March. 4, 2025 /PRNewswire/ -- Akita I S.à r.L., an entity indirectly controlled by an affiliate of the fund known as EQT VIII ("EQT") is pleased to announce the completion of the sale (the "Sale") of 20 million shares in Azelis Group NV (the "Company") for aggregate gross proceeds of c. EUR 366 million. As part of the Sale, EQT will receive gross proceeds of c. EUR 333 million. The Sale was completed on February 28, 2025. BNP Paribas, Goldman Sachs and J.P. Morgan acted as joint global coordinators for the Sale.

Mo., 24.02.2025       EQT
SE0012853455

The offering resulted in aggregate gross proceeds of USD920 million, of which EQT received c. USD393 million

NEW YORK, Feb. 24, 2025 /PRNewswire/ -- An affiliate of the fund known as EQT VIII ("EQT") is pleased to announce the completion of an underwritten public offering (the "Offering") of 23 million shares of common stock of Waystar Holding Corp. (NASDAQ: WAY) (the "Company") ("Shares") for aggregate gross proceeds of USD920 million. As part of the Offering, EQT sold c. 9.8 million Shares (and now holds c. 38.8 million Shares) and received gross proceeds of c. USD393 million. The remaining Shares sold in the Offering were sold by other stockholders of the Company. J.P. Morgan, Goldman Sachs & Co. LLC and Barclays acted as joint book-running managers of the Offering, which was completed on February 24, 2025, and as representatives of the several underwriters. The Company did not sell any Shares in the Offering and did not receive any proceeds from the sale of the Shares sold by EQT and the other stockholders.

Mo., 24.02.2025       EQT
SE0012853455

The offering resulted in aggregate gross proceeds of USD920 million, of which EQT received c. USD393 million

NEW YORK, Feb. 24, 2025 /PRNewswire/ -- An affiliate of the fund known as EQT VIII ("EQT") is pleased to announce the completion of an underwritten public offering (the "Offering") of 23 million shares of common stock of Waystar Holding Corp. (NASDAQ: WAY) (the "Company") ("Shares") for aggregate gross proceeds of USD920 million. As part of the Offering, EQT sold c. 9.8 million Shares (and now holds c. 38.8 million Shares) and received gross proceeds of c. USD393 million. The remaining Shares sold in the Offering were sold by other stockholders of the Company. J.P. Morgan, Goldman Sachs & Co. LLC and Barclays acted as joint book-running managers of the Offering, which was completed on February 24, 2025, and as representatives of the several underwriters. The Company did not sell any Shares in the Offering and did not receive any proceeds from the sale of the Shares sold by EQT and the other stockholders.

Mo., 17.02.2025       EQT
SE0012853455

The Board of Directors of EQT AB ("EQT") has appointed Per Franzén as new CEO and Managing Partner, effective as of the Annual Shareholders' Meeting on 27 May 2025. During this transition period, Christian Sinding will remain as CEO.Per Franzén has spent nearly two decades at EQT, currently serving as Deputy Managing Partner and Head of Private Capital Europe & North America. He has been instrumental to EQT's growth and success, most recently leading the EUR 22 billion raise of EQT X, which was the largest private equity fund closed globally in 2024.After the transition, Christian Sinding will become an Institutional Partner. In this role he will Chair the EQT Council, which brings together some of EQT's most experienced leaders with external expertise to build partnerships and provide EQT and its clients the insights needed to stay ahead in an ever-evolving world. He will also continue to Chair the Global Investment Forum and remain a member of several Investment Committees.
Mo., 17.02.2025       EQT
SE0012853455

The Board of Directors of EQT AB ("EQT") has appointed Per Franzén as new CEO and Managing Partner, effective as of the Annual Shareholders' Meeting on 27 May 2025. During this transition period, Christian Sinding will remain as CEO.Per Franzén has spent nearly two decades at EQT, currently serving as Deputy Managing Partner and Head of Private Capital Europe & North America. He has been instrumental to EQT's growth and success, most recently leading the EUR 22 billion raise of EQT X, which was the largest private equity fund closed globally in 2024.After the transition, Christian Sinding will become an Institutional Partner. In this role he will Chair the EQT Council, which brings together some of EQT's most experienced leaders with external expertise to build partnerships and provide EQT and its clients the insights needed to stay ahead in an ever-evolving world. He will also continue to Chair the Global Investment Forum and remain a member of several Investment Committees.
Mo., 17.02.2025       EQT
SE0012853455

The Board of Directors of EQT AB ("EQT") has appointed Per Franzén as new CEO and Managing Partner, effective as of the Annual Shareholders' Meeting on 27 May 2025. During this transition period, Christian Sinding will remain as CEO.Per Franzén has spent nearly two decades at EQT, currently serving as Deputy Managing Partner and Head of Private Capital Europe & North America. He has been instrumental to EQT's growth and success, most recently leading the EUR 22 billion raise of EQT X, which was the largest private equity fund closed globally in 2024.After the transition, Christian Sinding will become an Institutional Partner. In this role he will Chair the EQT Council, which brings together some of EQT's most experienced leaders with external expertise to build partnerships and provide EQT and its clients the insights needed to stay ahead in an ever-evolving world. He will also continue to Chair the Global Investment Forum and remain a member of several Investment Committees.
Di., 11.02.2025       EQT
SE0012853455

With both institutional and individual investors looking to semi-liquid strategies for diversification and customization, EQT broadens portfolio with the introduction of EQT Nexus InfrastructureEQT Nexus Infrastructure offers exposure to EQT's infrastructure strategies, direct investments in infrastructure companies in EQT's portfolio, and the same distinctive infrastructure investment approach EQT's institutional clients have benefited from for over fifteen years EQT is one of the world's largest infrastructure investors with three dedicated strategies: Value-Add, Active Core, and Transition Infrastructure
Di., 28.01.2025       EQT
SE0012853455

TravelPerk is an all-in-one SaaS business travel platform that aims to give travelers the freedom they want whilst providing companies with the control they need EQT Growth co-leads the round, which values TravelPerk at USD 2.7 billion, alongside Atomico; round also joined by new investors Noteus Partners and Sequoia Capital, as well existing investors like General Catalyst, Kinnevik, Softbank Vision Fund, and BlackstoneAlongside the financing, TravelPerk announces that it has acquired Yokoy, a leading spend management platform, to create an integrated Travel and Expense Management platform
Di., 28.01.2025       EQT
SE0012853455

Atalanta Therapeutics is pioneering RNA interference (RNAi) for the treatment of neurological diseases, having developed a proprietary platform that, for the first time enables RNAi to be deployed as a therapeutic approach throughout the brain and spinal cordThe USD 75 million Series B financing will support Phase 1 clinical trials of the company's investigational RNAi therapies for KCNT1-related epilepsy and Huntington's diseaseEQT Life Sciences is leading the round investing from its LSP Dementia Fund, which is co-led by Sanofi Ventures with further participation from RiverVest Venture Partners, abrdn, Inc., Mirae Asset Financial Group and F-Prime Capital
Do., 23.01.2025       EQT
SE0012853455

STOCKHOLM, Jan. 23, 2025 /PRNewswire/ -- Gearing up for long-term growth  

"Private markets are returning to their long-term growth trajectory. The global economy is growing, paced by Asia and the US, central banks have cut interest rates, and capital markets are robust albeit volatile. We live in times of rapid technological and societal shifts. At EQT we continuously adapt, while remaining focused on building resilient companies, infrastructure, and real estate. In 2024, we returned to record levels of investments, increased exit activity, drove significant value in our portfolios, and closed the largest private equity fund globally1. In recent years, we launched a number of new strategies and are now primed to hit the ground running as we embark on a new EUR 100 billion fundraising cycle."Christian Sinding,CEO and Managing Partner

We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S